| |
| | Nuclear Medicine Program |
 | | Other examples of HFIR-produced medical radioisotopes include high specific activity holmium-166 (from natural, high-purity Ho), lutetium-177 (from enriched Lu-176), platinum-195m (from enriched Pt-194) and tin-117m (from enriched Sn-117). |
 | | Plenary Lecture, “Therapeutic Applications of Rhenium-188 in Nuclear Medicine and Oncology – Current Status and Expected Future Perspectives,” for, International Conference on Radiopharmaceutical Therapy, organized by the World Therapy Council of the World Federation of Nuclear Medicine and Biology (WFNMB), Limassol, Cyprus, October 11-14, 2005. |
 | | Plenary Lecture, “The Continuing Important Role of Research Reactors for Production of Medical Radioisotopes,” International Symposium on Research Reactor and Neutron Science – in Commemoration of the 10th Anniversary, Korean Atomic Energy Research Institute (KAERI), Daejeon, Korea, on April 15-19, 2005. |
| www.ornl.gov /sci/nuclear_science_technology/nu_med/index.htm (698 words) |
|